UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063301
Receipt number R000072458
Scientific Title Prediction of post-extubation respiratory failure using HAMILTON-C6-derived respiratory drive and breathing-pattern indices and electrical impedance tomography in patients who pass a spontaneous breathing trial: a prospective single-center study
Date of disclosure of the study information 2026/10/16
Last modified on 2026/10/15 21:44:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to predict breathing deterioration after removal of a breathing tube using ventilator measurements and lung ventilation imaging

Acronym

C6-EIT Extubation Study

Scientific Title

Prediction of post-extubation respiratory failure using HAMILTON-C6-derived respiratory drive and breathing-pattern indices and electrical impedance tomography in patients who pass a spontaneous breathing trial: a prospective single-center study

Scientific Title:Acronym

C6-EIT Extubation Study

Region

Japan


Condition

Condition

Critically ill adults scheduled for liberation from invasive mechanical ventilation and extubation

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine, in invasively ventilated adults who successfully complete a spontaneous breathing trial (SBT) and are scheduled for extubation, whether the change in |P0.1| x rapid shallow breathing index (RSBI) from the early to the late phase of the SBT measured by HAMILTON-C6 and the absolute difference between ventral and dorsal ventilation distribution measured by electrical impedance tomography (EIT) 1-5 minutes after SBT initiation are associated with unplanned rescue noninvasive positive-pressure ventilation (NPPV) or reintubation due to respiratory deterioration within 72 hours after extubation, and to explore the predictive value of combining these indices.

Basic objectives2

Others

Basic objectives -Others

Risk prediction and exploration of predictors of post-extubation respiratory failure

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Occurrence of the composite outcome of unplanned rescue NPPV initiation or reintubation due to respiratory deterioration within 72 hours after extubation. Planned prophylactic NPPV or high-flow nasal cannula (HFNC) therapy alone will not be counted as an event.

Key secondary outcomes

Reintubation within 48 hours and within 7 days after extubation.

Unplanned rescue NPPV without reintubation within 72 hours after extubation.

Occurrence of objectively defined post-extubation respiratory failure within 72 hours and time from extubation to its onset.

Associations between the primary outcome and HAMILTON-C6-derived indices measured 1-5 and 25-30 minutes after SBT initiation, including |P0.1|, RSBI, respiratory rate, tidal volume, minute ventilation, and Cstat/predicted body weight, as well as their changes during the SBT.

Associations between the primary outcome and EIT-derived indices during the SBT, including the absolute ventral-to-dorsal ventilation distribution difference, dorsal ventilation fraction, center of ventilation, global inhomogeneity index, changes in end-expiratory lung impedance, and pendelluft, as well as their changes over time.

Associations of cough strength, the number of suctioning procedures during the 6 hours before extubation, and secretion burden with the primary outcome.

ICU length of stay, hospital length of stay, tracheostomy, ICU mortality, and in-hospital mortality.

Adverse events and device malfunctions related to EIT belt placement or research data acquisition.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adults aged 18 years or older.

Receiving invasive mechanical ventilation for at least 24 hours in the intensive care unit of Yamagata University Hospital.

Completion of a spontaneous breathing trial (SBT) lasting at least 30 minutes according to the institutional standard procedure, with the treating physician determining that the SBT was successful.

Extubation on the same day has been decided by the treating physician and is expected to occur approximately within 2 hours after the study measurements.

The SBT can be performed using a HAMILTON-C6 ventilator with software version 1.2.3 or later, and the required parameters, including P0.1, respiratory rate, and tidal volume, can be recorded.

Written informed consent can be obtained from the participant or a legally acceptable representative.

If a patient has multiple extubation opportunities, only the first eligible extubation will generally be enrolled.

Key exclusion criteria

Presence of a tracheostomy or planned tracheostomy after extubation.

A treatment-limitation decision specifying that reintubation will not be performed.

A significant endotracheal tube leak, bronchopleural fistula, flow-sensor malfunction, or another condition that may make HAMILTON-C6 measurements of ventilation or respiratory mechanics inaccurate.

Severe skin lesions at the EIT belt site, chest-wall anatomy, surgical wounds, medical devices, or other conditions preventing appropriate EIT measurement, or any contraindication to the EIT device.

Unstable hemodynamics, uncontrolled arrhythmia, persistent severe hypoxemia, or another condition making the study measurements unsafe.

Planned prophylactic NPPV immediately after extubation is considered mandatory, making it difficult to distinguish prophylactic from rescue NPPV. Routine planned HFNC use alone is not an exclusion criterion.

Current or possible pregnancy.

Any other condition considered unsuitable for study participation by the treating physician or principal investigator.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Tadahiro
Middle name
Last name Kobayashi

Organization

Yamagata University Faculty of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

990-9585

Address

2-2-2 Iida-Nishi, Yamagata City, Yamagata

TEL

023-628-5422

Email

ta-kobayashi@med.id.yamagata-u.ac.jp


Public contact

Name of contact person

1st name Tadahiro
Middle name
Last name Kobayashi

Organization

Yamagata University Faculty of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

9909585

Address

2-2-2 Iida-Nishi, Yamagata, Yamagata-pref, Japan

TEL

0236285422

Homepage URL


Email

ta-kobayashi@med.id.yamagata-u.ac.jp


Sponsor or person

Institute

Yamagata University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamagata University Faculty of Medicine Ethics Committee

Address

2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan

Tel

023-628-5047

Email

yu-ikekenkyu@jm.kj.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山形大学医学部附属病院(山形県)


Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 15 Day

Date of IRB

2026 Year 09 Month 28 Day

Anticipated trial start date

2026 Year 11 Month 15 Day

Last follow-up date

2029 Year 10 Month 31 Day

Date of closure to data entry

2029 Year 10 Month 31 Day

Date trial data considered complete

2029 Year 12 Month 31 Day

Date analysis concluded

2030 Year 03 Month 31 Day


Other

Other related information

This is a prospective, single-center, exploratory observational cohort study. Consecutive adult patients who have received invasive mechanical ventilation for at least 24 hours in the ICU of Yamagata University Hospital, successfully complete a standard spontaneous breathing trial (SBT), and are scheduled for same-day extubation will be enrolled. During the SBT performed as part of routine clinical care, HAMILTON-C6-derived indices of respiratory drive, breathing pattern, and respiratory mechanics and regional ventilation distribution measured by electrical impedance tomography (EIT) will be recorded. The study will not alter the SBT settings or duration, timing of extubation, or post-extubation treatment. The primary exposure variables are the change in |P0.1| x RSBI between 1-5 and 25-30 minutes after SBT initiation and the absolute difference between ventral and dorsal ventilation distribution measured by EIT at 1-5 minutes after SBT initiation. The primary outcome is unplanned rescue NPPV or reintubation due to respiratory deterioration within 72 hours after extubation. Planned prophylactic NPPV or HFNC alone will not be counted as an event. Eligible patients will be enrolled consecutively, with a target sample size of 150.


Management information

Registered date

2026 Year 10 Month 15 Day

Last modified on

2026 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072458